FdaApplication
NDA 207315
Identifiers
- fda_app_no: NDA207315
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD III |
| application_type | NDA |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE | LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE | 75MG;75MG | TABLET;ORAL |
1 product